MedTrace Logo

Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic Attack

NCT00479518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2017-02-27

No results posted yet for this study

Summary

Patients with stroke or transient ischemic attack (TIA) are at high risk of poor outcome, recurrence of cardiovascular events or vascular death.Until now, no reliable predictive biological marker could be identified in the acute phase of stroke.We hypothese that, in the acute phase of ischemic stroke or TIA, the increase of cardiac ( brain natriuretic peptide, BNP) or renal markers (albuminuria, cystatin C)might predict recurrence of cardiovascular events or vascular death. We want to assess which one of these markers has the best prognosis value , in a prospective study of 300 stroke patients followed during 3 years.

Conditions

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • BONNAUD Isabelle, MD · Service de Neurologie / CHRU de Tours

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2014-04-30
Completion
2017-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00479518 on ClinicalTrials.gov